Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: Changes in panic disorder and effects of alprazolam treatment

Biological Psychiatry

Volumn 41, Issue 1, 1997, Pages 76-85

  Curtis, George C ^a,c   Abelson, James L ^a   Gold, Philip W ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c Med Inn Bldg/0840 ^*  (United States)

Author keywords

adrenocorticotropic hormone; alprazolam; corticotropin releasing hormone; cortisol; panic disorder

Indexed keywords

ALPRAZOLAM; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PANIC; PRIORITY JOURNAL;

EID: 0031015632     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(95)00578-1     Document Type: Article

References (30)

1. Abelson JL, Cameron OG (1994): Adrenergic dysfunction in anxiety disorders. In Cameron OG (ed), Adrenergic Dysfunction and Psychobiology. Washington, DC: American Psychiatric Press, pp 403-446.
2. Abelson JL, Curtis GC (1996a): Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 53:323-331.
3. Abelson JL, Curtis GC (1996b): Hypothalamic-pituitary-adrenal axis activity in panic disorder: Pre-treatment cortisol predicts long-term outcome. Am J Psychiatry 153:69-73.
4. Abelson JL, Curtis GC, Cameron OG (1996): Hypothalamicpituitary-adrenal axis activity in panic disorder: Effects of alprazolam on 24-hour secretion of adrenocorticotropin and cortisol. J Psychiatr Res 30:79-93.
5. Amsterdam JD, Marinelli DL, Arger P, Winokur A (1987): Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: A pilot study. Psychiatry Res 21:189-197.
6. Amsterdam JD, Maislin G, Winokur A, Berwish N, Kling M, Gold P (1988): The oCRH stimulation test before and after clinical recovery from depression. J Affect Disord 14:213-222.
7. Ballenger J, Burrows G, DuPont RJ, et al (1988): Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: I. Efficacy in short-term treatment. Arch Gen Psychiatry 45:413-422.
8. Brambilla F, Bellodi L, Perna G, et al (1992): Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 26: 12-22.
9. Calogero AE, Gallucci WT, Chrousos GP, Gold PW (1988a): Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 463:28-36.
10. Calogero AE, Gallucci WT, Tomai TP, Loriaux DL, Chrousos GP, Gold PW (1988b): Inhibition of corticotropin releasing hormone secretion by GABA A and GABA B receptor action in vitro: Clinical implications. In D'Agata R, Chrousos GP (eds), Recent Advances in Adrenal Regulation and Function. New York: Raven Press, pp 279-284.
11. Chrousos GP, Gold PW (1992): The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis. JAMA 267:1244-1252.
12. Coryell W, Noyes R, Schlechte J (1989): The significance of HPA axis disturbance in panic disorder. Biol Psychiatry 25:989-1002.
13. Coryell W, Noyes R, Reich J (1991): The prognostic significance of HPA-axis disturbance in panic disorder: A three-year follow-up. Biol Psychiatry 29:96-102.
14. Gold PW, Chrousos GP (1985): Clinical studies with corticotropin releasing factor: Implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency. Psychoneuroendocrinology 10:401-419.
15. Gold PW, Calabrese JR, Kling MA, et al (1986): Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 10:57-65.
16. Grunhaus L, Flegel P, Haskett RF, Greden JF (1987): Serial dexamethasone suppression tests in simultaneous panic and depressive disorders. Biol Psychiatry 22:332-338.
17. Holsboer F, von Bardeleben U, Buller R, Heuser I, Steiger A (1987): Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res 16(suppl):80-88.
18. Jaeckle RS, Kathol RG, Lopez JF (1987): Enhanced adrenal sensitivity to exogenous ACTH1-24 stimulation in major depression: Relationship to dexamethasone suppression test result. Arch Gen Psychiatry 43:233-240.
19. Kathol RG, Jaeckle RS, Lopez JF, Meller WH (1989): Patho-physiology of HPA axis abnormalities in patients with major depression: An update. Am J Psychiatry 146:311-317.
20. Linkowski P, Medlewicz J, Leclercq R, et al (1985): The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 61:429-438.
21. Lopez JF, Young EA, Herman JP, Akil H, Watson SJ (1991): Regulatory biology of the HPA axis: An integrative approach. In Risch SC (ed), Central Nervous System Peptide Mechanisms in Stress and Depression. Washington, DC: American Psychiatric Press, pp 1-52.
22. Nemeroff CB, Krishnan KRR, Reed D, Leder R, Beam C, Dunnick NR (1992): Adrenal gland enlargement in major depression: A computed tomographic study. Arch Gen Psychiatry 49:384-387.
23. Rapaport MH, Risch SC, Golshan S, Gillin JC (1989): Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients. Biol Psychiatry 26:344-348.
24. Reiger DA, Burke JD, Burke KC (1990): Comorbidity of affective and anxiety disorders in the NIMH Epidemiologic Catchment Area Program. In Maser JD, Cloninger CR (eds), Cormorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press, pp 113-122.
25. Roth WT, Margraf J, Ehlers A, et al (1992): Stress test reactivity in panic disorder. Arch Gen Psychiatry 49:301-310.
26. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW (1986): The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899.
27. Schürmeyer TH, Tomai TP, Steinbach H, von zur Mühlen A, Gold PW (1988): Pituitary and adrenal responses to insulin induced hypoglycemia and to CRH are modulated by anxiolytic pretreatment in man. In D'Agata R, Chrousos GP (eds), Recent Advances in Adrenal Regulation and Function. New York: Raven Press, pp 285-291.
28. Spitzer RL, Williams JBW (1986): Structured Clinical Interview for DSM-III-R-Upjohn Version, rev. New York: Biometrics Research Department, New York State Psychiatric Institute.
29. Young EA, Akil H (1985): CRF Stimulation of ACTH/β-endorphin release: Effects of acute and chronic stress. Endocrinology 117:23-30.
30. Young EA, Akil H (1988): Paradoxical effects of corticosteroids on pituitary ACTH/β-endorphin release in stressed animals. Psychoneuroendocrinology 13:317-323.